Article: South Africa: since the initiation of its biotech strategy five years ago, South Africa has learned a lot about the biotech market, and is moving away from its tradition of academic research to the more profitable commercial science sectors.(Region Watch)

South Africa: Since the initiation of its biotech strategy five years ago, South Africa has learned a lot about the biotech market, and is moving away from its tradition of academic research to the more profitable commercial science sectors. To reach this goal, the government made a three-year investment of R 450 million ($70 million) in biotech in 2005 and will increase current R&D spending from 0.81% of GDP to 1% by 2008. The country will also address its need for experienced biotech managers and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!